Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ORTH - Undervalued stock at 17/32? -- Ignore unavailable to you. Want to Upgrade?

To: Buckey who wrote (22)	3/14/1999 8:37:00 AM
From: lac	Read Replies (1) \| Respond to of 99

I saw ORTH pop up on peoples radar screens Friday pm Upon investigation I see that most of ORTH's competition is "undervalued" (some more severely that are profitable), they are a relative newcomer in a field that could have more competition, they are short of cash, and even the Company admits that their ability to attract additional affiliates is risky. Additionally they seem to look for the lower end of the practice scale and count on bringing service and efficiency to the table to increase patient revenues. The idea is good if you have the $$, the stock price and the patience (no pun intended) to make it work. Maybe I'm missing something apart from the obvious, JrEwing but why this one instead of some of their competition? Jeff